Eradia 125 mg/ml oral suspension for dogs

Palatable, liquid metronidazole offering accurate and easy dosing for all dogs.

Eradia is a versatile and highly palatable liquid metronidazole suspension designed to make dosing easy for all dogs. Featuring an innovative, award-winning Smartcap lid, it ensures simple and accurate administration with no risk of spills. Its liquid form is especially suited for puppies and dogs with oral pain, helping to improve compliance and clinical outcomes.

Effective against obligate anaerobes (e.g. Clostridium spp.) and Giardia spp.
Highly palatable flavoured liquid , achieving 100% voluntary intake
¹ when administered on food.
Award-winning Smartcap technology ensures accurate dosing, no spills, and no product contact for the pet owner.
Flexible administration options can be given directly into the mouth or poured over food.
Suitable for puppies, with no adverse effects seen in 12 week old puppies given up to 5x the recommended dose.
Long in-use shelf life of up to 6 months (for 100ml bottle), facilitating longer-term treatments.

Available in The Republic of Ireland and Northern Ireland.

Technical support

Contact support teams with any question by phone or via our quick form.

Call us Contact us

Presentation

Flavoured oily oral suspension with brown visible particles. Available in 30ml and 100ml opaque white polyethylene terephthalate (PET) bottles. Each bottle is equipped with a plastic snap cap with silicon stopper (Smartcap technology) and includes a 3ml graduated polypropylene syringe for accurate dosing.

Indications

Treatment of infections of the gastrointestinal tract caused by Giardia spp. and Clostridium spp. (i.e. C. perfringens or C. difficile).

Treatment of infections of the urogenital tract, oral cavity, throat and skin caused by obligate anaerobic bacteria (e.g. Clostridium spp.) susceptible to metronidazole.

Clinical characteristics & efficacy

Metronidazole is the molecule of choice for anaerobes. It is highly lipophilic, allowing it to easily penetrate infected cells where it causes DNA fragmentation and inhibits protein synthesis.

Gastrointestinal Efficacy

In a study of anaerobic strains, 100% (61/61) of isolates collected from dogs with GI disease (including C. difficile and C. perfringens) were susceptible to metronidazole.
²
Eradia significantly decreases cyst excretion and reduces diarrhoea in Giardia-infected dogs.
³

Dental and Periodontal Efficacy

100% (35/35) of anaerobic isolates collected from dogs with periodontal disease were susceptible to metronidazole
² .

Pharmacokinetics

Absolute bioavailability is 98% in fasted dogs. While food slightly decreases oral bioavailability, it remains high at 81%, allowing for flexible administration with or without food.

Details: cache-cmh1290065-CMH 1794490804 1469100151

Varnish cache server

Associated products

Rilexine®

Browse all products